title: Clinical impact of breakpoint position within M-bcr in chronic myeloid leukemia.
abstract: We have analyzed the M-bcr breakpoint position in 133 Philadelphia-positive chronic myeloid leukemia patients and correlated the findings with clinical, hematologic, and cytogenetic data. We also investigated the splicing pattern of the BCR-ABL mRNA in 30 patients, using reverse transcriptase PCR. No statistically significant differences were found between breakpoint position within M-bcr and clinical parameters at diagnosis, the karyotypic evolution pattern, or the leukemic phenotype during blast crisis. Furthermore, the breakpoint position within M-bcr did not correlate with the duration of chronic phase or survival time. When the splicing pattern of the BCR-ABL mRNA was compared with the results of the genomic breakpoint mapping, it was found that approximately 60% (8/14) of the patients with a 5' break expressed b2a2 fusion mRNA, whereas all patients (10/10) with a 3' break expressed b3a2 BCR-ABL mRNA.
authors.affiliation: Department of Clinical Genetics, Lund University Hospital, Sweden.
authors.forename: T
authors.initials: T
authors.lastname: Fioretos
authors.forename: P G
authors.initials: PG
authors.lastname: Nilsson
authors.forename: P
authors.initials: P
authors.lastname: Aman
authors.forename: S
authors.initials: S
authors.lastname: Heim
authors.forename: U
authors.initials: U
authors.lastname: Kristoffersson
authors.forename: C
authors.initials: C
authors.lastname: Malm
authors.forename: B
authors.initials: B
authors.lastname: Simonsson
authors.forename: I
authors.initials: I
authors.lastname: Turesson
authors.forename: F
authors.initials: F
authors.lastname: Mitelman
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000704:Analysis of Variance; D016009:Chi-Square Distribution; D002648:Child; D002873:Chromosome Fragility; D002874:Chromosome Mapping; D002892:Chromosomes, Human, Pair 22; D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000235:genetics; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D005810:Multigene Family; D016133:Polymerase Chain Reaction; D011379:Prognosis; D011505:Protein-Tyrosine Kinases; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D051562:Proto-Oncogene Proteins c-bcr; D012326:RNA Splicing; D012333:RNA, Messenger / Q000235:genetics; D015996:Survival Rate
chemical_list: D011518:Proto-Oncogene Proteins; D012333:RNA, Messenger; D011505:Protein-Tyrosine Kinases; D016044:Fusion Proteins, bcr-abl; C496613:BCR protein, human; D051562:Proto-Oncogene Proteins c-bcr